Related Experiment Video
Updated: Sep 9, 2025
08:23
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
11.3K
Leveraging Functional and Structural Connectomics to Guide Neuromodulation in Epilepsy
Ketan Mehta1, Arianna Damiani2, Elvira Pirondini2
1Department of Biomedical Engineering, Duke University, Durham, North Carolina, U.S.A.
Summary
Epilepsy involves disrupted brain networks, not just structural issues. Precision neuromodulation uses connectivity data for tailored treatments targeting patient-specific seizure networks.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Epilepsy is increasingly understood as a network disorder, challenging traditional structural views.
- Thalamic neuromodulation is shifting from fixed interventions to dynamic, network-informed approaches.
Purpose of the Study:
- To review the role of functional and structural connectivity in understanding epilepsy.
- To highlight how connectivity data guides precision neuromodulation strategies for epilepsy.
Main Methods:
- Utilizing stereo-EEG for real-time neurophysiology.
- Employing diffusion MRI for structural network analysis.
- Applying advanced connectomic analyses to integrate data.
Main Results:
- Epilepsy is fundamentally a disorder of disrupted brain networks and inter-regional communication.
- Neurostimulation strategies are becoming individualized and responsive to patient-specific networks.
Conclusions:
- Precision neuromodulation integrates anatomic and functional connectivity for tailored epilepsy treatments.
- Network-informed strategies represent a paradigm shift in managing epilepsy through advanced neuromodulation.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
445
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445